evinacumab

evinacumab
Trade Name
Orphan Indication Treat of homozygous familial hypercholesterolemia
USA Market Approval USA
USA Designation Date 2016-02-08 00:00:00
Sponsor Regeneron Pharmaceuticals, Inc.;777 Old Saw Mill River Road;Tarrytown, New York, 10591